MOTS-c dosage
What is MOTS-c?
MOTS-c is a 16-amino-acid peptide that the body makes naturally. Unusually, its genetic code sits in the DNA of mitochondria (the energy-producing parts of cells) rather than in the cell nucleus. It was first described in 2015, and products sold today contain a lab-made copy.
How it works
In mouse and cell studies, MOTS-c acts mainly on skeletal muscle, where it is proposed to activate AMPK, an enzyme that works as a cellular fuel gauge. FDA reviewers note that its exact molecular target remains unknown.
What the evidence shows
No clinical trial has given MOTS-c itself to people: FDA reviewers found no clinical studies or human exposure data by any route. Human research is observational, measuring the body's own MOTS-c; levels rose in muscle and blood after exercise and were lower in older adults and in people with type 2 diabetes in some studies. In mice, MOTS-c prevented diet-induced obesity and insulin resistance and improved physical performance in old animals, but FDA cautions that this work is limited to rodents. A modified analog, CB4211, completed a phase 1 trial with 88 participants, but no results are posted on the registry. A lab study found MOTS-c breaks down quickly in human blood, raising doubt about whether injections reach active levels.
Reported side effects
- No human safety data exist for MOTS-c given as a product; its side effects are unknown
- No animal toxicity studies were identified by FDA reviewers
- Possible unwanted immune reactions with injections (FDA concern, not measured in trials)
Cautions
- FDA says the safety risks of MOTS-c in humans are unknown because no human data exist by any route.
- FDA is concerned that injected MOTS-c could trigger immune reactions through peptide clumping or impurities.
- Benefits seen in mice have not been confirmed in people.
- Naturally higher MOTS-c after exercise does not show that injecting it has the same effect.
Legal and regulatory status
MOTS-c is not FDA-approved and is not part of any FDA-approved drug. FDA lists it among compounding substances that may present significant safety risks. In July 2026 an FDA advisory committee voted to recommend allowing pharmacy compounding, against the proposal of FDA's own reviewers; as of October 2026 FDA had not acted on that vote. The WADA Prohibited List names MOTS-c as an AMPK activator under section S4.4 (metabolic modulators), banned at all times.
Common questions
Has MOTS-c been tested in humans?
Not as a treatment. Studies in people have only measured the body's own MOTS-c levels, and FDA reviewers found no clinical trials in which MOTS-c was given to human subjects.
Is MOTS-c really an exercise mimetic?
That label comes from mouse studies, where MOTS-c improved physical performance and metabolism. Exercise raises natural MOTS-c in human muscle and blood, but no human trial has tested whether taking it reproduces any benefit of exercise.
Is MOTS-c banned in sport?
Yes. It is listed by name on the WADA Prohibited List under S4.4, metabolic modulators, and is prohibited in and out of competition.
Sources
- FDA: Evaluation of MOTS-c for the Pharmacy Compounding Advisory Committee, July 2026
- FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
- FDA: PCAC briefing document introduction, July 23-24, 2026
- Mintz: FDA's advisory committee votes on peptides, what it does and does not change
- Cell Metabolism (PubMed abstract): The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis (2015)
- Nature Communications (PubMed abstract): MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline (2021)
- International Journal of Molecular Sciences: MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases (2022), via Europe PMC
- ClinicalTrials.gov: NCT03998514, phase 1a/1b study of CB4211
- Journal of Clinical Investigation: Mitochondria-derived peptides in aging and healthspan (2022), via Europe PMC
- WADA: 2026 Prohibited List (copy hosted by the Czech National Sports Agency)
Articles about MOTS-c
Personal experienceI Tried MOTS-c for 7½ Weeks. Here’s What Actually Happened to My Energy, Endurance, and Workouts.
MOTS-c reviews and Q&A
No reviews or questions yet. Be the first.
Get the printable dosing chart
All 50 peptides on a few pages, as a PDF. We’ll also email you when a peptide’s approval status or dosing changes.
More in Longevity & immune
Stacks that include MOTS-c
Compare MOTS-c
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.